clinical trial

By Laura Lovett 04:10 pm March 26, 2020
Yesterday morning ClinOne, a digital platform that helps researchers manage clinical trials, landed $3.6 million in Series A funding. The infusion of cash was led by CU Healthcare Innovation Fund. WHAT THEY DO The platform works with pharma companies, research groups, and clinical trial sites in order to recruit appropriate patients for their trial. Researchers can use the platform to manage ...
By Dave Muoio 11:47 am February 4, 2020
Inato, a Parisian startup revamping clinical trial enrollment, has pulled in a $14 million Series A round. Obvious Ventures and Cathay Innovation headed the raise, which also saw support from prior backers Serena and Fly Ventures. WHAT THEY DO Inato has developed a platform that helps biopharma clients select the optimal site for their clinical studies. Its technology incorporates logistical data...
By Laura Lovett 01:10 pm January 30, 2020
This morning, Massachusetts General Hospital (MGH), Google Cloud and digital clinical trial startup ProofPilot inked a deal to create a new clinical research platform targeted at academic medical centers and universities.  The trio plan to kick off this new platform with a study called “Piloting Time-Restricted Feeding (TRF) for Bipolar Disorder” at MGH.  The new collaboration will tap into...

Photo courtesy of Janssen Pharmaceutical Companies. From left to right: panel moderator Patrick Wayte, Dr. C. Michael Gibson and Dr. Paul Stoffels.

By Dave Muoio 01:23 pm November 18, 2019
Due to the promises of lower costs, simple scaling and greater patient engagement, digital technologies are all but an inevitability for the drug trials of tomorrow, according to experts from pharma and the clinical research community speaking this weekend at the American Heart Association Scientific Sessions in Philadelphia. These comments were accompanied by the official kickoff of CHIEF-HF,...
By Dave Muoio 03:50 pm November 7, 2019
AiCure, a nearly decade-old startup using artificial intelligence to measure medication adherence and other behavior during clinical trials or normal care, has brought in $24.5 million in Series C funding. Palisades Growth Capital led the raise, which also featured new backers Singtel Innov8, Asahi Kasei Corporation, Accelmed Growth Partners, and SpringRock Ventures. The round also included all...
By Laura Lovett 11:12 am September 11, 2019
When it comes to clinical trials, oftentimes the majority of a patient’s experience happens “off stage” in their home or community. For example, medication adherence, or nonadherence, has been a major pitfall in medicine. Studies have found that roughly one in five new prescriptions are never filled, and of those filled up to 50% are taken incorrectly.  Startups have taken notice and the digital...
By Dave Muoio 10:47 am July 31, 2019
Litmus Health announced yesterday the release of a new version of its device-friendly clinical research platform for the collection and analysis of real-world data. Built with new features to help pharmaceutical companies from the beginning to the end of their drug trials, the platform now adds Actigraph’s medical-grade wearables to its repertoire of supported devices, which previously included...

Verisense by Shimmer IMU (Photo courtesy Shimmer)

By Jonah Comstock 01:35 pm February 19, 2019
Shimmer, a Dublin-based wearable sensor company, has launched a new sensor platform for clinical trials called VeriSense. At launch, the platform will work with Shimmer's IMU, or inertial measurement unit, sensor, which can measure activity and sleep from the wrist, as well as network with sensors elsewhere on the body to monitor musculoskeletal and neurological conditions. The company has been...
By Laura Lovett 01:03 pm October 9, 2018
Biopharmaceutical service Parexel International Corporation is turning its attention to mobile and wearable technology to aid drug development and clinical research. This morning the Boston-based company announced a slew of new products that will be built on its Perceptive Cloud platform.  One of the new technologies uses Microsoft’s Azure App Services and will be able to send patient data to...
By Jonah Comstock 04:30 pm May 16, 2018
Cambridge, Massachusetts-based sensor maker MC10, known for its flexible and stretchable electronics, has received its first FDA 510(k) clearance for the BioStamp nPoint system. BioStamp nPoint is a more advanced version of the company's non-FDA cleared BioStampRC. "BiostampRC was primarily developed as an investigational tool, primarily used by academia, as well as by pharmaceutical companies,...